Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus

Experimental Dermatology

Volumn 19, Issue 2, 2010, Pages 123-131

  Järvinen, Tiina M ^a,b,c,d,e   Hellquist, Anna ^e   Koskenmies, Sari ^a,b   Einarsdottir, Elisabet ^b   Koskinen, Lotta L E ^b   Jeskanen, Leila ^a   Berglind, Linda ^f   Panelius, Jaana ^a   Hasan, Taina ^g   Ranki, Annamari ^a   Kere, Juha ^b,c,e   Saarialho Kere, Ulpu ^a,h  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^d Helsinki Biomedical Graduate School LERU PhD Programme in Biomedicine   (Finland)

^e KAROLINSKA INSTITUTE   (Sweden)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^h STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

CTLA4; Interferon pathway; IRF5; TYK2

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERFERON REGULATORY FACTOR 5; PROTEIN TYROSINE KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISCOID LUPUS ERYTHEMATOSUS; FEMALE; FINLAND; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; MACROPHAGE; MALE; NEUTROPHIL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERFERON REGULATORY FACTORS; LUPUS ERYTHEMATOSUS, DISCOID; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TYK2 KINASE; UP-REGULATION; YOUNG ADULT;

EID: 75149174779     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00982.x     Document Type: Article

References (52)

1. Kuhn A, Rondinone R, Doria A, Shoenfeld Y. 1st International Conference on Cutaneous Lupus Erythematosus Dusseldorf, Germany, September 1-5, 2004. Autoimmun Rev 2005, 4:66-78.
2. Lee H J, Sinha A A. Cutaneous lupus erythematosus: understanding of clinical features, genetic basis, and pathobiology of disease guides therapeutic strategies. Autoimmunity 2006, 39:433-444.
3. Sontheimer R D. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005, 4:253-263.
4. Tebbe B, Orfanos C E. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997, 6:96-104.
5. Lee L A, Bolognia J L, Jorizzo J L, Rapini R P. Lupus erythematosus. Dermatology 2008, 561-574. In, eds, Philadelphia, Mosby
6. Angotti C. Immunology of cutaneous lupus erythematosus. Clin Dermatol 2004, 22:105-112.
7. Hochberg M C. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987, 14:867-869.
8. Deapen D, Escalante A, Weinrib L. A revised estimate of twin concordance in systemic lupus erythematosus. Arthritis Rheum 1992, 35:311-318.
9. Molina V, Shoenfeld Y. Infection, vaccines and other environmental triggers of autoimmunity. Autoimmunity 2005, 38:235-245.
10. Sigurdsson S, Nordmark G, Goring H H. Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus. Am J Hum Genet 2005, 76:528-537.
11. Harley J B, Alarcon-Riquelme M E, Criswell L A. Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 2008, 40:204-210.
12. Hom G, Graham R R, Modrek B. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med 2008, 358:956-961.
13. Sigurdsson S, Nordmark G, Garnier S. A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet 2008, 17:2868-2876.
14. Graham R R, Kyogoku C, Sigurdsson S. Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proc Natl Acad Sci U S A 2007, 104:6758-6763.
15. Remmers E F, Plenge R M, Lee A T. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N Engl J Med 2007, 357:977-986.
16. Wenzel J, Tuting T. Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches. Exp Dermatol 2007, 16:454-463.
17. Graham D S, Akil M, Vyse T J. Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families. Rheumatology (Oxford) 2007, 46:927-930.
18. Hellquist A, Zucchelli M, Kivinen K. The human GIMAP5 gene has a common polyadenylation polymorphism increasing risk to systemic lupus erythematosus. J Med Genet 2007, 44:314-321.
19. Rhodes B, Vyse T J. The genetics of SLE: an update in the light of genome-wide association studies. Rheumatology (Oxford) 2008, 47:1603-1611.
20. Koskenmies S, Järvinen T M, Onkamo P. Clinical and laboratory characteristics of Finnish lupus erythematosus patients with cutaneous manifestations. Lupus 2008, 17:337-347.
21. Graham R R, Cotsapas C, Davies L. Genetic variants near TNFAIP3 on 6q23 are associated with systemic lupus erythematosus. Nat Genet 2008, 40:1059-1061.
22. Karassa F B, Trikalinos T A, Ioannidis J P. Role of the Fcgamma receptor IIa polymorphism in susceptibility to systemic lupus erythematosus and lupus nephritis: a meta-analysis. Arthritis Rheum 2002, 46:1563-1571.
23. Prokunina L, Castillejo-Lopez C, Oberg F. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 2002, 32:666-669.
24. van Heel D A, Udalova I A, De Silva A P. Inflammatory bowel disease is associated with a TNF polymorphism that affects an interaction between the OCT1 and NF(-kappa)B transcription factors. Hum Mol Genet 2002, 11:1281-1289.
25. Russell A I, Cunninghame Graham D S, Shepherd C. Polymorphism at the C-reactive protein locus influences gene expression and predisposes to systemic lupus erythematosus. Hum Mol Genet 2004, 13:137-147.
26. Suarez A, Lopez P, Mozo L, Gutierrez C. Differential effect of IL10 and TNF{alpha} genotypes on determining susceptibility to discoid and systemic lupus erythematosus. Ann Rheum Dis 2005, 64:1605-1610.
27. Graham D S, Wong A K, McHugh N J, Whittaker J C, Vyse T J. Evidence for unique association signals in SLE at the CD28-CTLA4-ICOS locus in a family-based study. Hum Mol Genet 2006, 15:3195-3205.
28. Kaufman K M, Kelly J A, Herring B J. Evaluation of the genetic association of the PTPN22 R620W polymorphism in familial and sporadic systemic lupus erythematosus. Arthritis Rheum 2006, 54:2533-2540.
29. Jurinke C, van den Boom D, Cantor C R, Koster H. Automated genotyping using the DNA MassArray technology. Methods Mol Biol 2002, 187:179-192.
30. Ide H, Nakagawa T, Terado Y, Kamiyama Y, Muto S, Horie S. Tyk2 expression and its signaling enhances the invasiveness of prostate cancer cells. Biochem Biophys Res Commun 2008, 369:292-296.
31. Nishio H, Matsui K, Tsuji H, Tamura A, Suzuki K. Immunolocalisation of the janus kinases (JAK) - signal transducers and activators of transcription (STAT) pathway in human epidermis. J Anat 2001, 198:581-589.
32. Barrett J C, Fry B, Maller J, Daly M J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
33. Schindler C, Levy D E, Decker T. JAK-STAT signaling: from interferons to cytokines. J Biol Chem 2007, 282:20059-20063.
34. De Veer M J, Holko M, Frevel M. Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol 2001, 69:912-920.
35. Bengtsson A A, Sturfelt G, Truedsson L. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus 2000, 9:664-671.
36. Minegishi Y, Saito M, Morio T. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity. Immunity 2006, 25:745-755.
37. Reefman E, de Jong M C, Kuiper H. Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus? Arthritis Res Ther 2006, 8:R156.
38. Niewold T B, Kelly J A, Flesch M H, Espinoza L R, Harley J B, Crow M K. Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients. Arthritis Rheum 2008, 58:2481-2487.
39. Mori T, Anazawa Y, Iiizumi M, Fukuda S, Nakamura Y, Arakawa H. Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53. Oncogene 2002, 21:2914-2918.
40. Baima B, Sticherling M. Apoptosis in different cutaneous manifestations of lupus erythematosus. Br J Dermatol 2001, 144:958-966.
41. Akgul B, Curten M, Haigis H, Rogosz I, Pfister H. Interferon regulatory factor 5.2 acts as a transcription repressor of Epidermodysplasia verruciformis-associated human papillomaviruses. Arch Virol 2006, 151:2461-2473.
42. Kyogoku C, Tsuchiya N. A compass that points to lupus: genetic studies on type I interferon pathway. Genes Immun 2007, 8:445-455.
43. Barreto M, Santos E, Ferreira R. Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet 2004, 12:620-626.
44. Lee Y H, Harley J B, Nath S K. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet 2005, 116:361-367.
45. Miot H A, Bartoli Miot L D, Haddad G R. Association between discoid lupus erythematosus and cigarette smoking. Dermatology 2005, 211:118-122.
46. Baechler E C, Batliwalla F M, Karypis G. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003, 100:2610-2615.
47. Millard T P, Kondeatis E, Cox A. A candidate gene analysis of three related photosensitivity disorders: cutaneous lupus erythematosus, polymorphic light eruption and actinic prurigo. Br J Dermatol 2001, 145:229-236.
48. Werth V P, Zhang W, Dortzbach K, Sullivan K. Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000, 115:726-730.
49. Fernando M M, Stevens C R, Sabeti P C. Identification of two independent risk factors for lupus within the MHC in United Kingdom families. PLoS Genet 2007, 3:e192.
50. Racila D M, Sontheimer C J, Sheffield A, Wisnieski J J, Racila E, Sontheimer R D. Homozygous single nucleotide polymorphism of the complement C1QA gene is associated with decreased levels of C1q in patients with subacute cutaneous lupus erythematosus. Lupus 2003, 12:124-132.
51. Lee-Kirsch M A, Gong M, Chowdhury D. Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nat Genet 2007, 39:1065-1067.
52. Zhernakova A, Eerligh P, Barrera P. CTLA4 is differentially associated with autoimmune diseases in the Dutch population. Hum Genet 2005, 118:58-66.